Get started
Author

Véronique Gelsi‐Boyer

Observed names: GELSI, Véronique, Gelsi-Boyer, Véronique, V Gelsi-Boyer, V. Gelsi-Boyer, V. Gelsi‐Boyer, Veronique Gelsi-Boyer, Véronique Gelsi-Boyer, Véronique Gelsi-Boyer, Véronique Gelsi-boyer, véronique gelsi‐boyer
Observed institutions: Université Paris-Sud, Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, University Hospital of Bern, Institut Gustave Roussy, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Université Paris Descartes, Université de la Méditerranée Aix-Marseille II
OpenAlex ID: A5074305377
Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
2009 · Véronique Gelsi‐Boyer, Virginie Trouplin, et al. · British Journal of Haematology · 589
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
2013 · Raphaël Itzykson, Olivier Kosmider, et al. · Journal of Clinical Oncology · 559
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
2011 · R Itzykson, O Kosmider, et al. · Leukemia · 480
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
2012 · Véronique Gelsi-Boyer, Mandy Brecqueville, et al. · Journal of Hematology & Oncology · 291
PDF
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
2009 · Olivier Kosmider, Véronique Gelsi-Boyer, et al. · Blood · 285
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
2010 · O Kosmider, V Gelsi-Boyer, et al. · Leukemia · 257
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
2009 · O. Kosmider, V. Gelsi-Boyer, et al. · Haematologica · 255
PDF
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
2012 · Frederik Damm, Olivier Kosmider, et al. · Blood · 244
Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
2005 · Véronique Gelsi-Boyer, Béatrice Orsetti, et al. · Molecular Cancer Research · 236
PDF
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
2013 · Frederik Damm, Virginie Chesnais, et al. · Blood · 226
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
2010 · Véronique Gelsi‐Boyer, Virginie Trouplin, et al. · British Journal of Haematology · 226
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
2010 · Julien Rocquain, Nadine Carbuccia, et al. · BMC Cancer · 180
PDF
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms
2012 · Mandy Brecqueville, Jérôme Rey, et al. · Genes Chromosomes and Cancer · 168
Myeloid malignancies: mutations, models and management
2012 · Anne Murati, Mandy Brecqueville, et al. · BMC Cancer · 163
PDF
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
2006 · Anne Letessier, Fabrice Sircoulomb, et al. · BMC Cancer · 138
PDF
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes
2008 · Véronique Gelsi-Boyer, Virginie Trouplin, et al. · BMC Cancer · 135
PDF
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
2009 · N Carbuccia, V Trouplin, et al. · Leukemia · 121
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
2013 · F Damm, R Itzykson, et al. · Leukemia · 113
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
2005 · A Murati, V Gelsi-Boyer, et al. · Leukemia · 107
Role ofASXL1andTP53mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
2015 · Raynier Devillier, Véronique Mansat-De Mas, et al. · Oncotarget · 86
PDF
A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
2006 · J Adélaïde, C Pérot, et al. · Leukemia · 78
Acute myeloid leukemia with myelodysplasia‐related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations
2012 · Raynier Devillier, Véronique Gelsi‐Boyer, et al. · American Journal of Hematology · 75
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
2022 · Sylvain Garciaz, Anne-Sophie Alary, et al. · Cancers · 65
PDF
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers
2020 · Alexandre Fagnan, Frederik Otzen Bagger, et al. · Blood · 58
PDF
Genomic analysis of myeloproliferative neoplasms in chronic and acute phases
2016 · Frédéric Courtier, Nadine Carbuccia, et al. · Haematologica · 57
Works count: 81
Citation count: 5,862
H-index: 33
I10-index: 47
Year
Topic
Type